Axsome Therapeutics, Inc. (AXSM)

183.65 +6.38 (+3.60%) USD  |  NASDAQ  |  Jan 20, 12:33
More

Axsome Therapeutics Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade